Meet Dr. Dietzek
Dr. Charles L. Dietzek, D.O., FACOS
A Leading New Jersey Vein Doctor
Dr. Charles L. Dietzek is a board certified Vascular Surgeon practicing since 1989. He was a faculty member and the Chief of Vascular Surgery at the University of Medicine and Dentistry of New Jersey-School of Osteopathic Medicine (UMDNJ-SOM) until July 2005. In August 2005, he founded the Vein & Vascular Institute. He remains a Clinical Assistant Professor of Surgery volunteer faculty at RowanSOM.
Dr. Dietzek has been named numerous times a "Top Doc" in both South Jersey Magazine and SJ Magazine. He has also been a "Top physician for Women" repeatedly. He has been featured on health segments on ABC6, NBC10 and national news programs. Total Vein Care, a national physician training course, was Co--Directed by Dr. Dietzek where he has trained more than 1000 physicians in state of the art vein treatment. He is an invited lecturer and respected leader in the treatment of venous disease. The Vein & Vascular Institute is a recognized Center of Excellence and a national training facility for visiting physicians in advanced vein techniques and the Venefit™ procedure.
Dr. Dietzek has practiced the full spectrum of vascular surgery including angiography, angioplasty, stents, atherectomy, extremity bypass, aortic aneurysm repair (endovascular stent grafting and formal surgery technique), dialysis access, carotid endarterectomy and wound care. He now focuses on Venous Disease evaluation and treatment.
Dr. Dietzek did his undergraduate education in Chemistry at Stony Brook University in New York. His medical school education at New York College of Osteopathic Medicine and his general surgery training at UMDNJ-SOM. He completed his vascular fellowship in Cleveland, Ohio.
Dr. Dietzek was Chief of Vascular Surgery and Medical Director of the Vascular Laboratory at Kennedy Health System (KHS) for 18 years. He was also the founding Medical Director of the Center for Wound Healing and Hyperbaric Medicine at KHS. Dr Dietzek has participated in multiple research studies and continues to be involved in clinical research.